Lozada, Keeran Aziel S.
HRN: 24-14-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2023
AMPICILLIN 250MG (VIAL)
11/30/2023
12/08/2023
IV
90mg
Q12
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes